Skip to content

Clinical trials

Phase 1/2 Lymphoma, Non-Hodgkin trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1/2 Country / region: France Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20071
20081
20122
20132
20164
20173
20181
20198
20214
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12
Completed11
Recruiting7
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Hoffmann-La Roche4
Celgene3
Gilead Sciences3
Incyte Corporation2
Novartis Pharmaceuticals2
AstraZeneca1
BeOne Medicines1
CRISPR Therapeutics AG1
CellCentric Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin33
Lymphoma9
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Follicular7
Recurrence6
Hodgkin Disease5
Leukemia5
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, B-Cell5
Lymphoma, Mantle-Cell5

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.